Patrick Colin

“For liquid solutions, BFS single-dose units were the ideal solution: sterile, single-use, and preservative-free. Unither’s journey, from small-scale production to global leadership, demonstrates that BFS technology is not only viable but has become the essential benchmark for many pharmaceutical applications.”
Patrick Colin, Founder of Unither